Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-175.75M
↓ 104% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-86.21M
Historical baseline
PeriodValueYoY Change
2025$-175.75M-21.0%
2024$-145.30M-8.2%
2023$-134.28M-6.0%
2022$-126.66M-191.6%
2021$-43.43M-45.9%
2020$-29.77M-42.5%
2019$-20.90M-54.2%
2018$-13.55M-